Neohelmanthicin A
Neohelmanthicin A (compound 3A) is a phenylpropanoid compound with antitumor activity. The IC50s of Neohelmanthicin A for inhibiting leukemia cell line EL4, breast cancer cell line S180 and breast cancer cell line MCF7 are 0.13 μM, 7 μM and 23 μM respectively[1].
Product Specifications
UNSPSC
12352005
Target
Others
Type
Natural Products
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/neohelmanthicin-a.html
Solubility
10 mM in DMSO
Smiles
C/C=C(C)\C(O[C@@H](C)[C@@](C)(O)C(O[C@@H](C)[C@@H](C1=CC(OC)=C(OCO2)C2=C1)OC(/C(C)=C\C)=O)=O)=O
Molecular Formula
C26H34O10
Molecular Weight
506.54
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-N12209/Neohelmanthicin-A-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-N12209/
Scientific Category
Natural Products
Clinical Information
No Development Reported
CAS Number
[920758-09-4]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CASC5 (Protein CASC5, ALL1-fused gene from Chromosome 15q14 Protein, AF15q14, Bub-linking Kinetochore Protein, Blinkin, Cancer Susceptibility Candidate gene 5 Protein, Cancer/Testis antigen 29, CT29, Kinetochore-null Protein 1, Protein D40/AF15q14, CASC5,
CASC5 (Protein CASC5, ALL1-fused gene from Chromosome 15q14 Protein, AF15q14, Bub-linking Kinetochore Protein, Blinkin, Cancer Susceptibility Candidate gene 5 Protein, Cancer/Testis antigen 29, CT29, Kinetochore-null Protein 1, Protein D40/AF15q14, CASC5,
